Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Heidelberg, Germany.
Heidelberg Center for Heart Rhythm Disorders (HCR), Heidelberg University Hospital, Heidelberg, Germany.
ESC Heart Fail. 2021 Oct;8(5):3737-3747. doi: 10.1002/ehf2.13494. Epub 2021 Jul 2.
Right bundle branch block (RBBB) after heart transplantation (HTX) is a common finding, but its impact on post-transplant survival remains uncertain. This study investigated the post-transplant outcomes of patients with complete RBBB (cRBBB) ≤ 30 days after HTX.
This registry study analysed 639 patients receiving HTX at Heidelberg Heart Center between 1989 and 2019. Patients were stratified by diagnosis of cRBBB ≤ 30 days after HTX. Analysis included recipient and donor data, medication, echocardiographic features, graft rejections, atrial fibrillation, heart rates, permanent pacemaker implantation and mortality after HTX including causes of death.
One hundred thirty-nine patients showed cRBBB ≤ 30 days after HTX (21.8%), 20 patients with pre-existing cRBBB in the donor heart (3.2%) and 119 patients with newly acquired cRBBB (18.6%). Patients with newly acquired cRBBB had a worse 1-year post-transplant survival (36.1%, P < 0.01) compared with patients with pre-existing cRBBB (85.0%) or without cRBBB (86.4%), along with a higher percentage of death due to graft failure (P < 0.01). Multivariate analysis indicated cRBBB ≤ 30 days after HTX as significant risk factor for 1-year mortality after HTX (HR: 2.20; 95% CI: 1.68-2.87; P < 0.01). Secondary outcomes showed a higher rate of an enlarged right atrium (P = 0.01), enlarged right ventricle (P < 0.01), reduced right ventricular function (P < 0.01), 30-day atrial fibrillation (P < 0.01) and 1-year permanent pacemaker implantation (P = 0.02) in patients with cRBBB after HTX.
Newly acquired cRBBB early after HTX is associated with increased post-transplant mortality.
心脏移植(HTX)后右束支传导阻滞(RBBB)是一种常见的发现,但它对移植后生存的影响尚不确定。本研究调查了 HTX 后 30 天内完全性 RBBB(cRBBB)≤30 天的患者的移植后结局。
本注册研究分析了 1989 年至 2019 年期间在海德堡心脏中心接受 HTX 的 639 名患者。根据 HTX 后 30 天内诊断为 cRBBB≤30 天的患者进行分层。分析包括受体和供体数据、药物、超声心动图特征、移植物排斥、心房颤动、心率、永久性起搏器植入以及包括死亡原因在内的 HTX 后死亡率。
139 例患者在 HTX 后 30 天内出现 cRBBB≤30 天(21.8%),20 例供体心脏存在预先存在的 cRBBB(3.2%),119 例患者出现新获得性 cRBBB(18.6%)。与预先存在的 cRBBB(85.0%)或无 cRBBB(86.4%)的患者相比,新发 cRBBB 的患者移植后 1 年生存率较差(36.1%,P<0.01),且因移植物衰竭导致的死亡百分比较高(P<0.01)。多变量分析表明,HTX 后 30 天内存在 cRBBB 是 HTX 后 1 年死亡率的显著危险因素(HR:2.20;95%CI:1.68-2.87;P<0.01)。次要结局显示,HTX 后出现 cRBBB 的患者右心房增大(P=0.01)、右心室增大(P<0.01)、右心室功能降低(P<0.01)、30 天心房颤动(P<0.01)和 1 年永久性起搏器植入(P=0.02)的发生率较高。
HTX 后新获得的 cRBBB 与移植后死亡率增加相关。